fridays glp-1 reviews | Telehealth Fridays GLP-1 Review: Program Structure,
Description
At 12 months, weight loss persisted at around 4%, with variability between agents, most notably liraglutide
Stay tuned next week on 23rd December for the full 2026 Health Populi TrendCast with a focus on digital health trends we anticipate will set the stage for CES 2026
Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies
Looking for more GLP-1 support
